US 11944644
T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof
granted A61KA61K2039/505A61K2039/804
Quick answer
US patent 11944644 (T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/804, A61K2239/28, A61K2239/31